Employers

Fatigue is costing more than you think
Identify undiagnosed sleep apnea across your workforce and reduce its impact

The business impact

Undiagnosed OSA leads to

The problem

Sleep apnea is common, costly, and mostly undiagnosed.

Employees with OSA experience chronic fatigue, reduced focus, and higher health risks

But most remain undiagnosed quietly impacting performance and driving up medical spend

The solution

Soliish makes sleep health accessible at scale

60-second AI selfie scan
no equipment needed

Employees complete it on their own device, anywhere

iPhone mockup

Identifies OSA risk using objective craniofacial markers

No disruption to existing benefits or workflows

Why it matters for employers

Better sleep drives measurable business outcomes

From selfie to scalable sleep care pathways
Partner with Soliish to reimagine the journey together

Designed for scale

Whether you’re covering 500 or 50,000 employees:
No hardware or onsite setup
Works across distributed and remote teams
Easy to roll out through existing benefits programs
Minimal lift for HR and benefits teams

Frequently asked questions

1.

How does sleep apnea affect employee productivity and healthcare costs?

IconIcon

Sleep apnea is one of the most under-diagnosed conditions in the US workforce, and it costs employers in three direct ways: higher medical claims for downstream conditions like hypertension, diabetes, and cardiovascular disease, lost productivity from chronic fatigue and impaired concentration, and increased absenteeism and disability risk. Research suggests untreated sleep apnea costs the US economy roughly $150 billion annually, with employers absorbing a meaningful share of that through claims and lost work output.

2.

How many of my employees are likely to have undiagnosed sleep apnea?

IconIcon

Research suggests obstructive sleep apnea affects between 10 and 30 percent of adults depending on the population, and roughly 80 percent of moderate-to-severe cases remain undiagnosed. In a workforce of 1,000 employees, that means 100 to 300 individuals are likely to be living with the condition, and most don't know it. The gap is widest in employees who don't fit traditional risk profiles, including women and non-obese employees with anatomical risk factors.

3.

How does Soliish work as an employer benefit?

IconIcon

Soliish provides AI-powered sleep apnea risk screening that employees can complete privately on any smartphone, in 60 seconds, with no app to download. Employees who screen at elevated risk are automatically connected to a licensed sleep telehealth provider for evaluation and, if appropriate, diagnosis and prescription. The full pathway, from screening to therapy, runs on the Soliish platform with HIPAA-compliant data handling throughout.

4.

What does the employee experience look like?

IconIcon

Employees access Soliish through a secure link delivered by email, SMS, or a benefits portal. The AI selfie scan and brief intake take about 60 seconds. Results are delivered privately to the employee, never to the employer. If elevated risk is identified, the employee can self-schedule a telehealth consultation directly from the platform. Diagnosis, prescription, and therapy fulfilment happen through licensed providers in the Soliish network, with no additional steps required from the employer.

5.

Is employee health information shared with the employer?

IconIcon

No. Individual employee health data, including screening results, diagnoses, and treatment information, is never shared with the employer. Soliish operates as a HIPAA-compliant medical platform, and all clinical data flows between the employee and licensed providers. Employers receive only aggregated, de-identified reporting on programme engagement and population-level outcomes, similar to how other clinical benefits report performance.

6.

How does Soliish integrate with existing benefits and wellness programmes?

IconIcon

Soliish integrates with most major benefits administration platforms, wellness vendors, and employee communication channels. The screening and care pathway can be deployed as a standalone benefit, embedded into an existing wellness portal, or activated through targeted campaigns to specific employee segments. Most enterprise rollouts go live within 30 to 60 days, with no hardware procurement and no new clinical infrastructure required.

7.

How is Soliish different from a wellness app or a consumer sleep tracker?

IconIcon

Wellness apps and consumer sleep trackers raise general awareness but don't connect employees to clinical care. Soliish is a medical platform: the AI selfie scan generates a clinical risk signal, and elevated-risk employees are routed directly to licensed sleep physicians for evaluation, diagnosis, and prescription. The pathway ends in clinical outcomes, not engagement metrics. For procurement, this matters because the cost-impact case for sleep apnea programmes depends on employees actually reaching diagnosis and treatment.

8.

What is the return on investment for an employer sleep apnea programme?

IconIcon

Studies indicate that treated sleep apnea reduces downstream medical claims for cardiovascular and metabolic conditions, lowers absenteeism, improves measurable productivity metrics, and reduces accident rates in safety-sensitive roles. The ROI strengthens when the programme captures employees who would otherwise remain undiagnosed for years, because earlier identification compounds savings over time. Soliish provides employer-specific ROI modelling during the evaluation process, based on workforce size, demographics, and current benefits structure.